World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
29817
World Ranking
1426
National Ranking
726

Medicine

D-Index
83
Citations
29817
World Ranking
15474
National Ranking
7804

Theodore C. Pierson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Theodore C. Pierson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 159 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Theodore C. Pierson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Theodore C. Pierson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Theodore C. Pierson is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily focuses on Medicine, with significant contributions in Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Immunology, and Virology. The scientist's work covers a wide range of topics related to viral infections and disease control.

The main topics of their research include:

  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • Virology and Viral Diseases
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Malaria Research and Control
  • Viral Infections and Outbreaks Research

Theodore C. Pierson has published extensively, with frequent appearances in several notable scientific journals. The major publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Microbiology
  • npj Vaccines
  • The Journal of Infectious Diseases
  • Science Translational Medicine

Their recent papers demonstrate a continuing focus on emerging viral threats and vaccine research. These include:

  • The continued threat of emerging flaviviruses (2020, Nature Microbiology)
  • Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets (2021, Science)
  • The Challenges of Vaccine Development against a New Virus during a Pandemic (2020, Cell Host & Microbe)
  • Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes (2020, JAMA)
  • Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates (2021, npj Vaccines)

Theodore C. Pierson collaborates with a range of researchers, showing repeated co-authorship with:

  • Kimberly A. Dowd
  • Katherine E. Burgomaster
  • John R. Mascola
  • Barney S. Graham
  • Peter D. Kwong

Best Publications

  • Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

    Diana Finzi;Monika Hermankova;Theodore Pierson;Lucy M. Carruth

  • Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

    Diana Finzi;Joel N Blankson;Janet M Siliciano;Joseph Bernard Margolick

  • The continued threat of emerging flaviviruses

    Theodore C. Pierson;Michael S. Diamond

  • 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members

    Stephane Daffis;Kristy J. Szretter;Jill Schriewer;Jianqing Li

  • Modified mRNA Vaccines Protect against Zika Virus Infection.

    Justin M. Richner;Sunny Himansu;Kimberly A. Dowd;Scott L. Butler

  • Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu

  • The 3.8 Å resolution cryo-EM structure of Zika virus

    Devika Sirohi;Zhenguo Chen;Lei Sun;Thomas Klose

  • Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy

    Theodore Pierson;Justin McArthur;Robert F. Siliciano

  • The 3.8 angstrom resolution cryo-EM structure of Zika virus.

    D Sirohi;Z Chen;L Sun;T Klose

  • The emergence of Zika virus and its new clinical syndromes.

    Theodore C. Pierson;Michael S. Diamond

  • Rapid development of a DNA vaccine for Zika virus

    Kimberly A. Dowd;Sung-Youl Ko;Kaitlyn M. Morabito;Eun Sung Yang

  • West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.

    Carl W. Davis;Hai-Yen Nguyen;Sheri L. Hanna;Melissa D. Sánchez

  • Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.

    Yefei Han;Kara Lassen;Daphne Monie;Ahmad R. Sedaghat

  • Structural Basis of Zika Virus-Specific Antibody Protection.

    Haiyan Zhao;Estefania Fernandez;Kimberly A. Dowd;Scott D. Speer

  • A CRISPR screen defines a signal peptide processing pathway required by flaviviruses

    Rong Zhang;Jonathan J. Miner;Matthew J. Gorman;Keiko Rausch

  • The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

    Theodore C. Pierson;Qing Xu;Steevenson Nelson;Theodore Oliphant

  • Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.

    Theodore Oliphant;Grant E. Nybakken;Michael Engle;Qing Xu

  • Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo

    Kevin Whitby;Theodore C. Pierson;Brian Geiss;Kelly Lane

  • Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control

    Michael S. Diamond;Theodore C. Pierson

  • Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.

    Theodore C. Pierson;Daved H. Fremont;Richard J. Kuhn;Michael S. Diamond

Frequent Co-Authors

Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Daved H. Fremont
Daved H. Fremont Washington University in St. Louis
Robert W. Doms
Robert W. Doms Children's Hospital of Philadelphia
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
John R. Mascola
John R. Mascola ModeX Therapeutics
Robert F. Siliciano
Robert F. Siliciano Johns Hopkins University School of Medicine
Richard Kuhn
Richard Kuhn Purdue University West Lafayette
Stephen S. Whitehead
Stephen S. Whitehead National Institute of Allergy and Infectious Diseases
Syd Johnson
Syd Johnson AstraZeneca (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields online can open up diverse career opportunities. Advanced degrees such as a Psychiatric-Mental Health Nurse Practitioner (PMHNP) can complement immunology knowledge, especially when focused on autoimmune and neuroimmune disorders. Prospective students can find the best pmhnp programs online that emphasize quality clinical training and robust placement rates.

Cost is another important factor when choosing an online program. The cheapest online pmhnp programs offer accessible avenues for professionals seeking to expand their qualifications without a hefty financial burden.

Career advancement frequently ties into salary potential and specialized certifications. Data on dnp salary variations by state can help guide decisions about where to practice or focus further education. Additionally, immunology professionals with a nursing background might consider transitioning to more acute care roles. Guidance on acute care certification for fnp serves as a valuable resource for those looking to broaden their clinical expertise and impact.

Best Scientists Citing Theodore C. Pierson

Trending Scientists

Recently Published Articles